Alpha-Fetoprotein (AFP)
on cobas e immunoassay analyzers.
▪ 1st incubation a biotinylated monoclonal AFP‑specific antibody, and a monoclonal AFP‑specific antibody labeled with a ruthenium complexa) react to form a sandwich complex.
▪ 2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and streptavidin.
▪ The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell II M. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.
▪ Results are determined via a calibration curve which is instrument specifically generated by 2‑point calibration and a master curve provided via the cobas link
Serum, Sodium/Lithium Heparin plasma, Amniotic fluid
150 uL
The discovery of alpha-fetoprotein (AFP) in fetal serum was first recorded by Bergstrand and Czar in 1956.
Alpha-fetoprotein is a single polypeptide chain glycoprotein with a molecular weight of approximately 70,000 daltons. It is secreted into fetal serum, reaching a peak at about 13 weeks gestation and gradually declining thereafter. Elevated serum AFP levels subsequently reappear during pregnancy and in conjunction with several malignant diseases
Browse tests by laboratory
Customer Service
Toll Free: 1-855-381-3212
Local: 416-813-7200